The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 26, 2021

Filed:

May. 23, 2018
Applicant:

Biogaia Ab, Stockholm, SE;

Inventors:

James Versalovic, Bellaire, TX (US);

Carissa Michelle Thomas, Houston, TX (US);

Eamonn Connolly, Lindingo, SE;

Assignee:

BIOGAIA AB, Stockholm, SE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/747 (2015.01); A23L 33/135 (2016.01); C12Q 1/04 (2006.01); A61K 35/741 (2015.01); G01N 33/569 (2006.01); A61K 31/4172 (2006.01); A61K 35/74 (2015.01); A23L 33/175 (2016.01); A61K 31/7004 (2006.01); A61K 45/06 (2006.01); A61K 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 35/747 (2013.01); A23L 33/135 (2016.08); A23L 33/175 (2016.08); A61K 31/4172 (2013.01); A61K 31/7004 (2013.01); A61K 35/74 (2013.01); A61K 35/741 (2013.01); A61K 45/06 (2013.01); C12Q 1/04 (2013.01); G01N 33/56911 (2013.01); A23V 2002/00 (2013.01); A23Y 2220/71 (2013.01); A61K 2035/115 (2013.01); G01N 2333/335 (2013.01);
Abstract

A method is provided of selecting specific probiotic lactic acid bacteria producing histamine and the use of such strains for beneficial effects for mammals. The method includes selecting a lactic acid bacterial strain for use in the local production of histamine in a mammal, and further comprises screening bacteria for the presence of an active histidine operon and selecting a strain which has an active histidine operon and is capable of producing histamine. Preferably said strain is selected for its ability to produce histamine at a level of greater than 250 pg/ml. The present invention further provides products comprising the strains obtainable by the selection methods of the invention for use in the local production of histamine in a mammal, in particular for use in the treatment or prophylaxis of inflammatory conditions.


Find Patent Forward Citations

Loading…